Does BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Cause Haematochezia? 120 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 120 reports of Haematochezia have been filed in association with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS. This represents 68.2% of all adverse event reports for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS.
120
Reports of Haematochezia with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
68.2%
of all BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS reports
0
Deaths
88
Hospitalizations
How Dangerous Is Haematochezia From BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS?
Of the 120 reports, 88 (73.3%) required hospitalization.
Is Haematochezia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS. However, 120 reports have been filed with the FAERS database.
What Other Side Effects Does BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Cause?
Nausea (139)
Anaemia (132)
Headache (132)
Pyrexia (132)
Constipation (128)
Pain (128)
Erythema (127)
Female genital tract fistula (127)
Oral candidiasis (126)
Proctitis (126)
What Other Drugs Cause Haematochezia?
VEDOLIZUMAB (5,215)
ADALIMUMAB (4,008)
INFLIXIMAB (3,539)
ASPIRIN (2,379)
RIVAROXABAN (1,623)
MESALAMINE (1,456)
CLOPIDOGREL BISULFATE (1,390)
APIXABAN (1,312)
METHOTREXATE (1,133)
TOFACITINIB (1,118)
Which BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Alternatives Have Lower Haematochezia Risk?
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BILASTINE
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST\TIMOLOL
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB-BKZX